ArticleRMD open2026

Impact of trial exclusion criteria on real-world comparative effectiveness of targeted therapies in rheumatoid arthritis: the FIRST Registry.

Satoshi Kubo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.